Diagnostics Biochem Canada Inc.

Click Here To EMAIL INQUIRY
Contact: Judy Sessions - Director of Marketing & Sales
Web: http://www.dbc-labs.com
E-Mail:
Address: 1020 Hargrieve Rd., London, Ontario N6E 1P5, Canada
Phone: +1-(519)-681-8731 | Fax: +1-(519)-681-8731 | Map/Directions >>

Profile: Diagnostics Biochem Canada Inc. develops kits and reagents using radioimmunoassay and chemiluminescence. We have raised many polyclonal antibodies especially in the domain of steroids. We nave tested hundreds of polyclonal antibodies to find out their titers and specificities. We have now developed 13 CliA kits, and more kits are continuously appearing on the market. Our Elisa kits and Lia kits are used for the direct determination of steroids, proteins & tumor markers in human serum and saliva. Our polyclonal antibodies are raised in rabbits and characterized in our laboratory. We are able to supply any reagent on an OEM basis. We can easily coat antibodies on micro titer plates or used antibodies.

The company was founded in 1973, has revenues of < USD 1 Million, has ~10 employees.

FDA Registration Number: 8010132
US Agent: Kevin Walls / Regulatory Insight Inc.
Phone: +1-(720)-962-5412 Fax: +1-(720)-962-5413 E-Mail:

25 Products/Services (Click for related suppliers)

• 17-Hydroxyprogesterone Radioimmunoassay Test (FDA Code: JLX / 862.1395)

A 17-hydroxyprogesterone test system is a device intended to measure 17-hydroxyprogesterone (a steroid) in plasma and serum. Measurements of 17-hydroxyprogesterone are used in the diagnosis and treatment of various disorders of the adrenal glands or the ovaries.

• Aldosterone Radioimmunoassay Test (FDA Code: CJM / 862.1045)

An aldosterone test system is a device intended to measure the hormone aldosterone in serum and urine. Aldosterone measurements are used in the diagnosis and treatment of primary aldosteronism (a disorder caused by the excessive secretion of aldosterone by the adrenal gland), hypertension caused by primary aldosteronism, selective hypoaldosteronism, edematous states, and other conditions of electrolyte imbalance.

• Androstenedione Radioimmunoassay Test (FDA Code: CIZ / 862.1075)

An androstenedione test system is a device intended to measure androstenedione (a substance secreted by the testes, ovary, and adrenal glands) in serum. Adrostenedione measurements are used in the diagnosis and treatment of females with excessive levels of androgen (male sex hormone) production.

• Anti-Thyroglobulin Autoantibodies

• Anti-Thyroid Peroxidase Autoantibodies

• Carcinoembryonic Antigen Kits

• Cortisol

• Dehydroepiandrosterone Sulfate Testing Kit

• Enzyme Immunoassay Test

• Enzymeimmunoassay Kits

• Estradiol Radioimmunoassay Test (FDA Code: CHP / 862.1260)

An estradiol test system is a device intended to measure estradiol, an estrogenic steroid, in plasma. Estradiol measurements are used in the diagnosis and treatment of various hormonal sexual disorders and in assessing placental function in complicated pregnancy.

• Estrone Radioimmunoassay Test (FDA Code: CGF / 862.1280)

An estrone test system is a device intended to measure estrone, an estrogenic steroid, in plasma. Estrone measurements are used in the diagnosis and treatment of numerous disorders, including infertility, amenorrhea, differentiation of primary and secondary ovarian malfunction, estrogen secreting testicular and ovarian tumors, and precocious puberty in females.

• Follicle Stimulating Hormone (FSH)

• Follicle Stimulating Hormone Radioimmunoassay (FDA Code: CGJ / 862.1300)

A follicle-stimulating hormone test system is a device intended to measure follicle-stimulating hormone (FSH) in plasma, serum, and urine. FSH measurements are used in the diagnosis and treatment of pituitary gland and gonadal disorders.

• Human Chorionic Gonadotropin System

• Human Growth Hormone Radioimmunoassay (FDA Code: CFL / 862.1370)

A human growth hormone test system is a device intended to measure the levels of human growth hormone in plasma. Human growth hormone measurements are used in the diagnosis and treatment of disorders involving the anterior lobe of the pituitary gland.

• Luteinizing Hormone

• Luteinizing Hormone Radioimmunoassay (FDA Code: CEP / 862.1485)

A luteinizing hormone test system is a device intended to measure luteinizing hormone in serum and urine. Luteinizing hormone measurements are used in the diagnosis and treatment of gonadal dysfunction.

• Ovarian Cancer Antigen

• Pregnenolone Radioimmunoassay (FDA Code: JNG / 862.1615)

A pregnenolone test system is a device intended to measure pregnenolone (a precursor in the biosynthesis of the adrenal hormone cortisol and adrenal androgen) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of diseases of the adrenal cortex or the gonads.

• Progesterone Radioimmunoassay Test (FDA Code: JLS / 862.1620)

A progesterone test system is a device intended to measure progesterone (a female hormone) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of disorders of the ovaries or placenta.

• Prolactin Radioimmunoassay (FDA Code: CFT / 862.1625)

A prolactin (lactogen) test system is a device intended to measure the anterior pituitary polypeptide hormone prolactin in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of disorders of the anterior pituitary gland or of the hypothalamus portion of the brain.

• Radioimmunoassay for Dehydroepiandrosterone Sulfate (FDA Code: JKC / 862.1245)

A dehydroepiandrosterone (free and sulfate) test system is a device intended to measure dehydroepiandrosterone (DHEA) and its sulfate in urine, serum, plasma, and amniotic fluid. Dehydroepiandrosterone measurements are used in the diagnosis and treatment of DHEA-secreting adrenal carcinomas.

• Testosterones and Dihydrotestosterone Radioimmunoassay (FDA Code: CDZ / 862.1680)

A testosterone test system is a device intended to measure testosterone (a male sex hormone) in serum, plasma, and urine. Measurement of testosterone are used in the diagnosis and treatment of disorders involving the male sex hormones (androgens), including primary and secondary hypogonadism, delayed or precocious puberty, impotence in males and, in females hirsutism (excessive hair) and virilization (masculinization) due to tumors, polycystic ovaries, and adrenogenital syndromes.

• Total Triiodothyronine Radioimmunoassay (FDA Code: CDP / 862.1710)

A total triiodothyronine test system is a device intended to measure the hormone triiodothyronine in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases such as hyperthyroidism.